The Safety of the Temozolomide in Patients with Malignant Glioma

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|1|2|205-222

ISSN： 1574-8863

Source： Current Drug Safety, Vol.1, Iss.2, 2006-05, pp. : 205-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

By Sabel Michael   Giese Alf  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3239-3257

Informa Healthcare

Access to resources Recommend Favorite

Safety Profile of the Use of Iodopovidone for Pleurodesis in Patients with Malignant Pleural Effusion

By  

Respiration, Vol. 90, Iss. 5, 2015-0 ,pp. : 369-375

Karger

Access to resources Recommend Favorite

Management of Malignant Glioma – Quo Vadis?

By  

Oncology Research and Treatment, Vol. 31, Iss. 6, 2008-05 ,pp. : 300-302

Karger

Access to resources Recommend Favorite

Temozolomide in Patients with High Grade Gliomas

By  

Oncology, Vol. 59, Iss. 3, 2000-10 ,pp. : 181-186

Karger

Access to resources Recommend Favorite

Localized BCNU chemotherapy and the multimodal management of malignant glioma

By La Rocca Renato V.   Mehdorn H. Maximilian  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 149-160

Informa Healthcare

Access to resources Recommend Favorite